Back to today’s briefing

Story perspectives

Heart Device Funding Cuts Endanger Young Lives, Expert Warns

10/9/2025

28 6

Summary

Story summary

Caleb, a 4-year-old awaiting a heart transplant, relies on a ventricular assist device for heart failure.
The PediaFlow, an implantable infant heart developed by James Antaki, had federal funding canceled by the Trump administration, halting support.
Antaki says the decision harms vulnerable children and leaves his lab shut down without restored funds.

1 of 1

Story summary

Caleb, a 4-year-old awaiting a heart transplant, relies on a ventricular assist device for heart failure.
The PediaFlow, an implantable infant heart developed by James Antaki, had federal funding canceled by the Trump administration, halting support.
Antaki says the decision harms vulnerable children and leaves his lab shut down without restored funds.